• FOLLOW
SPANISH

CENTRO DE INVESTIGACION DEL CANCER

  1. Adolfo Álvarez Ferrando galardonado con el V Premio Nacional de Investigación en Cáncer “Doctores Diz Pintado”

    Actualidad

    Adolfo Álvarez Ferrando galardonado con el V Premio Nacional de Investigación en Cáncer “Doctores Diz Pintado”

    READ MORE
  2. Presentación de resultados del proyecto internacional Halifax sobre terapias de amplio espectro con baja toxicidad

    Actualidad

    Presentación de resultados del proyecto internacional Halifax sobre terapias de amplio espectro con baja toxicidad

    READ MORE
  3. Publicada la referencia global de variación genética humana

    Actualidad

    Publicada la referencia global de variación genética humana

    READ MORE

    meetings

Luis Paz-Ares

Precision Medicine in Lung Cancer: what´s in the horizon?

11/02/2016 - 11/02/2016
Luis Paz-Ares
Hospital 12 de Octubre [Madrid, Spain],

READ MORE

Javier Cañueto

Definición del pronóstico del carcinoma epidermoide cutáneo mediante la combinación de factores clínico-patológicos, marcadores proteicos y expresión de mi

18/02/2016 - 18/02/2016
Javier Cañueto
Centro de Investigación del Cáncer, (CIC-IBMCC), lab. 7 y Servicio de Dermatología (Hospital Universitario de Salamanca). ,

READ MORE

Papers

Infection causes childhood leukemia.
Hauer J, Martín-Lorenzo A, Sánchez-García I, 
Aging (Albany NY);2015-Sep;();;26412458

Infection exposure is a causal factor in B-precursor acute lymphoblastic leukemia as a result of Pax5 inherited susceptibility.
Martin-Lorenzo A, Hauer J, Vicente-Duenas C, Auer F, Gonzalez-Herrero I, Garcia-Ramirez I, Ginzel S, Thiele R, Constantinescu SN, Bartenhagen C, Dugas M, Gombert M, Schafer D, Blanco O, Mayado A, Orfao A, Alonso-Lopez D, De Las Rivas J, Cobaleda C, Garcia-Cenador MB, Garcia-Criado FJ, Sanchez-Garcia I, Borkhardt A, 
Cancer Discov;2015-Sep;();;26408659

Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?
Brown G, Sanchez-Garcia I, 
Oncotarget;2015-Oct;();;26498146

VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage.
Salzano M, Sanz-García M, Monsalve DM, Moura DS, Lazo PA, 
Epigenetics;2015-May;10(5);373-83;25923214

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.
Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, Irish J, Stehr H, Vicente-Dueñas C, Romero-Camarero I, Sanchez-Garcia I, Plevritis SK, Arber DA, Batzoglou S, Levy R, Alizadeh AA, 
Proc. Natl. Acad. Sci. U.;2015-Mar;112(10);E1116-25;25713363

THE DISEASE-LINKED Glu-26-Lys MUTANT VERSION OF CORONIN 1A EXHIBITS PLEIOTROPIC AND PATHWAY-SPECIFIC SIGNALING DEFECTS.
Ojeda V, Robles-Valero J, Barreira M, Bustelo XR, 
Mol. Biol. Cell;2015-Jun;();;26108624

A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.
Castillo-Lluva S, Hontecillas-Prieto L, Blanco-Gómez A, Del Mar Sáez-Freire M, García-Cenador B, García-Criado J, Pérez-Andrés M, Orfao A, Cañamero M, Mao JH, Gridley T, Castellanos-Martín A, Pérez-Losada J, 
Oncogene;2015-Jun;();;26096931

A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
Rosado C, Bueno E, Fraile P, García-Cosmes P, González-Sarmiento R, 
Eur J Med Genet;2015-Jan;58(1);35-8;25450602

The Spinal Muscular Atrophy with Pontocerebellar Hypoplasia Gene VRK1 Regulates Neuronal Migration through an Amyloid-β Precursor Protein-Dependent Me
Vinograd-Byk H, Sapir T, Cantarero L, Lazo PA, Zeligson S, Lev D, Lerman-Sagie T, Renbaum P, Reiner O, Levy-Lahad E, 
J. Neurosci.;2015-Jan;35(3);936-42;25609612

Designing a broad-spectrum integrative approach for cancer prevention and treatment.
Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AM, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HP, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HM, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M, 
Semin. Cancer Biol.;2015-Dec;35S();S276-S30;26590477

Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking.
Zhu S, Zhao C, Wu Y, Yang Q, Shao A, Wang T, Wu J, Yin Y, Li Y, Hou J, Zhang X, Zhou G, Gu X, Wang X, Bustelo XR, Zhou J, 
Nat. Neurosci.;2015-Aug;18(8);1084-93;26147533

How tumour cell identity is established?
Sánchez-García I, 
Semin. Cancer Biol.;2015-Apr;();;25931389

Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
Sánchez-Bailón MP, Calcabrini A, Mayoral-Varo V, Molinari A, Wagner KU, Losada JP, Ciordia S, Albar JP, Martín-Pérez J, 
Oncotarget;2015-Apr;();;25980494

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.
Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Nowsheen S, 
Semin. Cancer Biol.;2015-Apr;();;25892662

VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle.
Cantarero L, Sanz-García M, Vinograd-Byk H, Renbaum P, Levy-Lahad E, Lazo PA, 
Sci Rep;2015-;5();10543;26068304